ReShape Lifesciences shares fall as Q3 loss widens

Vyome Holdings

11/11/2021 17:17

** Shares of weight-loss co  RSLS.O  down ~4% at $2.43
    ** Co's Q3 loss widens to $17.7 mln, or $1.48 per share,
from $5.2 mln, or $1.32 per share a year earlier, due to heavy
marketing expenses and costs related to its buying of Obalon
Therapeutics in June  urn:newsml:reuters.com:*:nGNX7HQ9wt
    ** RSLS shares trading below their 50-, 150- and, 200-day
moving average price
    ** Including session's loss, stock has fallen 45.84% YTD
    

 (Reporting by Oishee Majumdar in Bengaluru)
 ((oishee.majumdar@thomsonreuters.com;))